Satellite cells

Satellite cells are tissue-resident muscle stem cells lying quiescent between the sarcolemma and the basal lamina of mature skeletal muscle fibers, identifiable by Pax7 expression. First described by Alexander Mauro in 1961 via electron microscopy, they activate in response to mechanical overload, muscle damage, or anabolic signals, whereupon they proliferate, commit to myogenic differentiation through MyoD and myogenin, and either fuse into myofibers or self-renew to replenish the stem cell pool. Their role in hypertrophy is tied to the myonuclear domain hypothesis — each myonucleus governs a finite cytoplasmic volume — meaning fiber growth beyond a threshold requires satellite cell-derived nuclear donation. With advancing age, the pool contracts: Pax7+ cell density per fiber declines in human biopsies from around the sixth decade onward, and cells shift from quiescence toward senescence, driven by epigenetic drift and niche disruption (impaired Notch signaling, altered fibro-adipogenic progenitor crosstalk, elevated TGF-β). A 2020 review by Chen, Datzkiw, and Rudnicki (Open Biology) found niche dysfunction partially reversible with exercise in rodent models. A 2023 systematic review and meta-analysis by Dewi et al. (Sports Medicine) confirmed that resistance exercise reliably expands the Pax7+ pool in human skeletal muscle; evidence for aerobic exercise remains limited. Whether satellite cell decline drives sarcopenia or is a downstream consequence of fiber atrophy remains unresolved in human causal terms.